Compounds > 3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone

3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone and Cardiovascular-Diseases

3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone has been researched along with Cardiovascular-Diseases* in 1 studies

Other Studies

1 other study(ies) available for 3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone and Cardiovascular-Diseases

ArticleYear
Increased intracellular Cl
    Acta pharmacologica Sinica, 2022, Volume: 43, Issue:11

    Neutrophil extracellular traps (NETs) play crucial roles in atherosclerotic cardiovascular diseases such as acute coronary syndrome (ACS). Our preliminary study shows that oxidized low-density lipoprotein (oxLDL)-induced NET formation is accompanied by an elevated intracellular Cl

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Cardiovascular Diseases; Cystic Fibrosis Transmembrane Conductance Regulator; Extracellular Traps; Humans; Mice

2022